USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/20343
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMargineanu, Cătălina-
dc.contributor.authorJugaru, Doiniţa-
dc.contributor.authorBarbu, Elena-
dc.contributor.authorJuganaru, Victoria-
dc.date.accessioned2022-03-28T06:59:14Z-
dc.date.available2022-03-28T06:59:14Z-
dc.date.issued2012-
dc.identifier.citationMARGINEANU, Cătălina, JUGARU, Doiniţa, BARBU, Elena, JUGANARU, Victoria. Multidrug resistant tuberculosis. In: MedEspera: the 4th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2012, p. 75.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/20343-
dc.description.abstractBackground: In recent years there is an increasing incidence of multidrug resistant tuberculosis which has important medical, social and economical consequences. Patients and methods: We report the case of a 44 year old male, smoker which was diagnosed in 2005 with multidrug resistant pulmonary tuberculosis. The patient is from an old disease outbreak, his father had pulmonary TB. Results: The patient was hospitalized in 2005 and 2006 with secondary bilateral fibrocaseus ulcerating pulmonary tuberculosis and right pleural tuberculosis with positive BK in sputum culture. He followed and completed the treatment strictly supervised (first-line regimen) and in the second month of treatment BK was negative. Five months after the treatment ended the patient was hospitalized with reactivated pulmonary TB, miliary form, BK positive in sputum culture. Antibiogram showed the existence of resistant BK stains at three first-line antituberculosis drugs: Isoniazid, Rifampicin and Streptomycin. There was established an individualized treatment with four drugs which included reserve drugs. The treatment lasted 23 months with a smooth evolution of the patient with radiological improvement and bacteriological negativation. Conclusions: In severe chronic MDR-TB are important: a correct clinical and laboratory diagnosis, completed appropriate treatment regimen, monitoring results, patient behavior including his education regarding the disease.en_US
dc.language.isoenen_US
dc.publisherState Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association, Scientific Association of Students and Young Doctorsen_US
dc.relation.ispartofMedEspera: The 4th International Medical Congress for Students and Young Doctors, May 17-19, 2012, Chisinau, Republic of Moldovaen_US
dc.titleMultidrug resistant tuberculosisen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2012

Files in This Item:
File Description SizeFormat 
MULTIDRUG_RESISTANT_TUBERCULOSIS.pdf51.81 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback